Skip to main
HQY

HealthEquity (HQY) Stock Forecast & Price Target

HealthEquity (HQY) Analyst Ratings

Based on 10 analyst ratings
Buy
Strong Buy 20%
Buy 70%
Hold 0%
Sell 0%
Strong Sell 10%

Bulls say

HealthEquity is a leader in the growing healthcare technology market and has established a strong presence through its mobile app and marketplace. In addition, the company's focus on sustainability and commitment to expansion opportunities provide a promising outlook for future growth. With a low valuation and strong potential for continued success, HealthEquity's stock presents a compelling investment opportunity for those looking to gain exposure to the healthcare technology sector.

Bears say

HealthEquity is poised for potential growth and operating margin expansions, with its transformation into a digital platform offering multiple sources of monetization and increased efficiencies. However, risky factors like falling interest rates and growing competition could hinder its growth and margin growth potential as well as uncertain post-pandemic recovery. Despite a strong account and HSA growth, near-term labor market conditions could also pose a threat to its growth. This outlook is supported by HealthEquity trading at a discount to its historical mean, with a 12.9x 2026 EBITDA estimate and a 19.6x 2026 P/E, indicating potential for a re-rate.

HealthEquity (HQY) has been analyzed by 10 analysts, with a consensus rating of Buy. 20% of analysts recommend a Strong Buy, 70% recommend Buy, 0% suggest Holding, 0% advise Selling, and 10% predict a Strong Sell.

This aggregate rating is based on analysts' research of HealthEquity and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About HealthEquity (HQY) Forecast

Analysts have given HealthEquity (HQY) a Buy based on their latest research and market trends.

According to 10 analysts, HealthEquity (HQY) has a Buy consensus rating as of Sep 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $113.80, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $113.80, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

HealthEquity (HQY)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.